Onchocerciasis: the role of Wolbachia bacterial endosymbionts in parasite biology, disease pathogenesis, and treatment.
about
A novel bacterial symbiont in the nematode Spirocerca lupiDoxycycline plus ivermectin versus ivermectin alone for treatment of patients with onchocerciasisDoxycycline plus ivermectin versus ivermectin alone for treating onchocerciasisChronic filarial infection provides protection against bacterial sepsis by functionally reprogramming macrophagesResearch for new drugs for elimination of onchocerciasis in AfricaWIPO Re:Search: Accelerating anthelmintic development through cross-sector partnershipsAnti-Wolbachia drug discovery and development: safe macrofilaricides for onchocerciasis and lymphatic filariasisImmunoepidemiological profiling of onchocerciasis patients reveals associations with microfilaria loads and ivermectin intake on both individual and community levelsA host as an ecosystem: Wolbachia coping with environmental constraints.Both asymmetric mitotic segregation and cell-to-cell invasion are required for stable germline transmission of Wolbachia in filarial nematodes.Significant heterogeneity in Wolbachia copy number within and between populations of Onchocerca volvulusModelling the impact of ivermectin on River Blindness and its burden of morbidity and mortality in African Savannah: EpiOncho projections.Migratory phase of Litomosoides sigmodontis filarial infective larvae is associated with pathology and transient increase of S100A9 expressing neutrophils in the lung.Endosymbiotic bacteria associated with nematodes, ticks and amoebae.Comparative analysis of the secretome from a model filarial nematode (Litomosoides sigmodontis) reveals maximal diversity in gravid female parasites.Human and animal dirofilariasis: the emergence of a zoonotic mosaic.Wolbachia lipoproteins: abundance, localisation and serology of Wolbachia peptidoglycan associated lipoprotein and the Type IV Secretion System component, VirB6 from Brugia malayi and Aedes albopictus.Human filarial Wolbachia lipopeptide directly activates human neutrophils in vitroHyperreactive onchocerciasis is characterized by a combination of Th17-Th2 immune responses and reduced regulatory T cells.Reductions in microfilaridermia by repeated ivermectin treatment are associated with lower Plasmodium-specific Th17 immune responses in Onchocerca volvulus-infected individuals.Retarded Onchocerca volvulus L1 to L3 larval development in the Simulium damnosum vector after anti-wolbachial treatment of the human host.Long term impact of large scale community-directed delivery of doxycycline for the treatment of onchocerciasis.Ophthalmic parasitosis: a review article.Validation of onchocerciasis biomarker N-acetyltyramine-O-glucuronide (NATOG).Minocycline as a re-purposed anti-Wolbachia macrofilaricide: superiority compared with doxycycline regimens in a murine infection model of human lymphatic filariasis.Onchocerciasis, an undiagnosed disease in Mozambique: identifying research opportunities.Host defense at the ocular surfaceWolbachia endosymbionts induce neutrophil extracellular trap formation in human onchocerciasis.NOD2 dependent neutrophil recruitment is required for early protective immune responses against infectious Litomosoides sigmodontis L3 larvae.Important progress towards elimination of onchocerciasis in the West Region of Cameroon.Functional attributes of evolutionary conserved Arg45 of Wolbachia (Brugia malayi) translation initiation factor-1.Evaluation of Onchocerciasis Transmission in Tanzania: Preliminary Rapid Field Results in the Tukuyu Focus, 2015.Patency of Litomosoides sigmodontis infection depends on Toll-like receptor 4 whereas Toll-like receptor 2 signalling influences filarial-specific CD4(+) T-cell responses.A five-year-old child with a subcutaneous forehead nodule.Retinoid Expression in Onchocercal Skin Disease: Pilot Study.Onchodermatitis: Where Are We Now?
P2860
Q21192735-F1492FED-D48A-45D2-BFA7-39C632F13D02Q24186468-BEDA37DB-5668-4DF5-8442-0F585D766B06Q24194317-8867B2B6-18AD-4DF3-88C4-35B30B58E941Q27321497-19168D3D-26C4-448F-B839-137672060769Q28066402-F3517EC9-9FB0-4168-A237-4788E8D8EB63Q28254042-BD318951-8630-4A9D-9E74-B6893062DC4CQ28294770-103BA8D9-3CEC-4A97-9EFD-634E5B7352DFQ28539936-A63ADB50-1E1A-4875-81B6-38786579CD6EQ30364992-BB8AD97D-8C8A-459B-9357-BA15863C2A0CQ30528769-21E401E6-9504-417A-8D3C-17DB3E5ABF55Q33576552-EAA787AF-B45E-4911-BE47-809E1585106DQ33681574-5B5D6286-D73F-4A47-90EC-79477CA05ACDQ33708053-231DBB03-D21A-4E60-A656-2FF9D79696A2Q34086072-18087BD9-3D2D-4795-B6F6-6E0835388988Q34303323-708CA884-7148-4E7E-8C75-9FD5D88003F2Q34327101-76F03026-6BB1-4C41-BBCE-023C891F550CQ34339870-9A951677-31DB-4E70-A3EC-31DFD96BD7E7Q34805265-0D737E27-DF29-4087-A85D-67C6E29ED53BQ34888523-AA024EEB-0EFF-40C4-B9B3-BAD6B2A947CFQ35343217-C6DBEA1D-D39C-4598-8ADD-A2A23031B674Q35848894-F0D1D1CD-1CD5-497B-9F66-B21065CC3820Q35953546-EED84F68-D78D-45E8-8DF9-288F3623CFA0Q36277588-E006F221-6A06-45AA-9524-1219FF88A7FBQ36397256-8A99B9E8-3B22-4001-B70A-CA2FD33C4B5CQ36708214-A07C7012-0606-4E98-84B4-E48683272EE8Q36749086-19A2554D-287E-4551-A944-3C1E95390789Q37114405-43D6926B-2866-4301-9D1B-6403A478D739Q37345869-93B5DC87-625B-461A-B4C3-98194D9DCD9DQ37526074-B8D0A955-2750-4725-AF09-BAA7C9BC0B76Q38642873-C2175F02-9648-45D6-B17B-49DCDCB3103DQ38910936-0072DF56-117D-4A11-BC2C-1657F50DB029Q39343801-99D9B910-1F32-44EF-B1D8-125AAEE9942BQ40852684-CAA3AF4D-29D4-46C2-9DBC-71C1C6B58078Q45882400-7961F8AA-66A0-4DDC-BD64-271F3101677BQ47741957-87E63BB4-AE00-47C1-BB0D-41785013941FQ57130087-FBD2D9E4-1739-4EEF-B5C3-2C0CF2712713
P2860
Onchocerciasis: the role of Wolbachia bacterial endosymbionts in parasite biology, disease pathogenesis, and treatment.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Onchocerciasis: the role of Wo ...... e pathogenesis, and treatment.
@ast
Onchocerciasis: the role of Wo ...... e pathogenesis, and treatment.
@en
Onchocerciasis: the role of Wo ...... e pathogenesis, and treatment.
@nl
type
label
Onchocerciasis: the role of Wo ...... e pathogenesis, and treatment.
@ast
Onchocerciasis: the role of Wo ...... e pathogenesis, and treatment.
@en
Onchocerciasis: the role of Wo ...... e pathogenesis, and treatment.
@nl
prefLabel
Onchocerciasis: the role of Wo ...... e pathogenesis, and treatment.
@ast
Onchocerciasis: the role of Wo ...... e pathogenesis, and treatment.
@en
Onchocerciasis: the role of Wo ...... e pathogenesis, and treatment.
@nl
P2093
P2860
P356
P1476
Onchocerciasis: the role of Wo ...... e pathogenesis, and treatment.
@en
P2093
Alice Halliday
Eric Pearlman
Francesca Tamarozzi
Katrin Gentil
Mark J Taylor
P2860
P304
P356
10.1128/CMR.00057-10
P407
P577
2011-07-01T00:00:00Z